Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NTRK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
GTF2H2C_2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERO1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIF25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLEC11A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HDAC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAD18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPB41L4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAPN13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJC10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC105376689 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
DCLK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SDK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUCKS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACACA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAPN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WSB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on